financetom
Business
financetom
/
Business
/
US Defense Department Signs $500 Million Contract With Honeywell
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
US Defense Department Signs $500 Million Contract With Honeywell
Mar 25, 2026 7:58 AM

Honeywell ( HON ) shares are up on Wednesday as the company penned a groundbreaking agreement with the U.S. Department of Defense to enhance production capabilities.

This positive momentum comes amid a strong performance in the broader market, with major indices like the S&P 500 and Nasdaq both gaining ground.

Commits $500M in Defense Deal

Honeywell ( HON ) announced a deal of $500 million to upgrade its production capacity under this new agreement. This marks a significant investment in defense technologies.

This framework agreement positions Honeywell Aerospace as a key supplier, enabling the company to meet urgent demands for critical capabilities in national defense.

The agreement highlights Honeywell’s focus on delivering advanced technologies across various sectors, including aerospace, defense, and industrial automation.

Planned Spin-off of Honeywell Aerospace

This month, Honeywell ( HON ) has advanced its planned separation of Honeywell Aerospace by filing a Form 10 registration statement with the SEC. This marks a pivotal step toward creating an independent, publicly traded aerospace and defense company.

The new entity is expected to list on Nasdaq under the ticker HONA, with the spin-off targeted for the third quarter of 2026.

Related to the spin-off, the company priced a senior notes offering. This includes two categories. "New Money Notes" to raise capital, totaling $10.5 billion, and "Exchange Notes," totaling $6.5 billion, which won’t raise new funds.

HON 5% Below 20-Day SMA

Honeywell’s stock is currently trading 5% below its 20-day simple moving average (SMA) and 3.4% below its 50-day SMA, suggesting some short-term weakness. However, it is trading 4.7% above its 100-day SMA and 6.4% above its 200-day SMA, indicating longer-term strength.

Shares have increased 11.95% over the past 12 months and are currently closer to their 52-week highs than to their lows, reflecting a solid upward trend in the stock’s performance.

HON EPS Seen $2.32; Revenue $9.27B

Honeywell International, Inc. ( HON ) is slated to provide its next financial update on April 28, 2026 (estimated).

EPS Estimate: $2.32 (Down from $2.51)

Revenue Estimate: $9.27 billion (Down from $9.82 billion)

Valuation: P/E of 31.9x (Indicates premium valuation)

Analyst Consensus & Recent Actions: The stock carries a Buy Rating with an average price target of $252.17. Recent analyst moves include:

Morgan Stanley: Equal-Weight (Raises Target to $245.00) (Mar. 12)

Jefferies: Hold (Raises Target to $245.00) (Mar. 4)

Barclays: Overweight (Raises Target to $275.00) (Mar. 4)

HON ETF Weights: NATO 5.38%, PPA 4.40%

Invesco Aerospace & Defense ETF ( PPA ) : 4.40% Weight

Themes Transatlantic Defense ETF ( NATO ) : 5.38% Weight

BrandywineGLOBAL-Dynamic US Large Cap Value ETF ( DVAL ) : 4.22% Weight

Significance: Because HON carries significant weight in these funds, any significant inflows or outflows for these ETFs will likely force automatic buying or selling of the stock.

HON Stock Price Activity: Honeywell Intl ( HON ) shares were up 0.70% at $223.11 at the time of publication on Wednesday, according to Benzinga Pro data.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Guardant Health, Boehringer Collaborate on Companion Test for Potential Lung Cancer Drug
Guardant Health, Boehringer Collaborate on Companion Test for Potential Lung Cancer Drug
Dec 18, 2024
08:59 AM EST, 12/18/2024 (MT Newswires) -- Guardant Health ( GH ) said Wednesday that it is collaborating with German pharmaceutical company Boehringer Ingelheim to seek regulatory approval and commercialize Guardant360 CDx liquid biopsy test as a companion diagnostic for Boehringer's investigational non-small cell lung cancer drug zongertinib. Under the collaboration, Guardant said its Guardant360 CDx blood test would provide...
ChargePoint Inks Pact With General Motors - Eyes Installing Ultra-fast Charging Ports At Key Locations
ChargePoint Inks Pact With General Motors - Eyes Installing Ultra-fast Charging Ports At Key Locations
Dec 18, 2024
ChargePoint Holdings, Inc ( CHPT ). shares are trading higher on Wednesday. ChargePoint ( CHPT ) and General Motors ( GM ) Company have announced a strategic partnership to accelerate the growth of electric vehicle infrastructure across the U.S. The two companies will work together to install hundreds of ultra-fast charging ports at key locations, aiming to improve access to...
Gray Media, Atlanta Braves Partner on Game Broadcasts Starting 2025
Gray Media, Atlanta Braves Partner on Game Broadcasts Starting 2025
Dec 18, 2024
09:02 AM EST, 12/18/2024 (MT Newswires) -- Gray Media (GTN) and Atlanta Braves ( BATRA ) have signed a multi-year partnership beginning in 2025 to simulcast 15 regular-season games with FanDuel Sports Network, Gray Media said Wednesday. Additionally, Gray said it will exclusively produce and broadcast 10 spring training games. ...
Toro Fiscal Q4 Adjusted Earnings, Net Sales Rise; Fiscal 2025 Non-GAAP EPS, Revenue Growth Guidance Issued
Toro Fiscal Q4 Adjusted Earnings, Net Sales Rise; Fiscal 2025 Non-GAAP EPS, Revenue Growth Guidance Issued
Dec 18, 2024
09:02 AM EST, 12/18/2024 (MT Newswires) -- The Toro Co. ( TTC ) reported fiscal Q4 adjusted earnings Wednesday of $0.95 per diluted share, up from $0.71 a year earlier. Analysts polled by FactSet expected $0.95. Net sales for the quarter ended Oct. 31 were $1.08 billion, compared with $983.2 million a year earlier. Analysts surveyed by FactSet expected $1.09...
Copyright 2023-2026 - www.financetom.com All Rights Reserved